Stitches have been used in medicine for centuries, and the procedure hasn't changed much. Due to advances in sutures and suture alternatives, surgeons are able to close wounds faster and with less trauma to the patients. The type of material used is determined by factors such as the type of injury being repaired or procedure being done, healing time, and the patient's condition. It is important to be aware of the properties of each, so that you can have a meaningful discussion with your physician/surgeon.
healtheo360 Wellness Blog
Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the two primary cannabinoids that occur naturally in the Cannabis sativa plant, most commonly known as cannabis.
Both of these substances interact with the cannabinoid receptors found in the human body and brain, but they differed dramatically in their effects. Check out this infographic for a quick comparison of THC and CBD:
Bipolar disorder is the 6th leading cause of disability in the world and results in 9.2 years reduction in expected life span.(1)
Cutaneous T-Cell Lymphoma (CTCL) is a rare form of cancer affecting immune cells, particularly T-cells, in the skin. It is classified as a Non-Hodgkin lymphoma and is one of the least common types. CTCL preferentially affects men, occurring in men about twice as commonly as women and appearing in mid to late adulthood between the ages of 40 and 70. This infographic was designed to provide basic information about the disease and some of the most common treatment options:
Cutaneous T-Cell Lymphoma (CTCL) is a type of lymphoma, or cancer of the immune cells, that arises in T-cells in the skin (primarily). T-cells are an integral part of the immune system, helping to recognize and fight against viruses, bacteria, and even other types of cancers. CTCL is a rare form of non-Hodgkin lymphoma and is most common in the skin, but may affect the blood, lymph nodes, and other internal organs as well. This disease affects men more often than women, and usually occurs between the ages of 40 and 70. There are many forms of treatment that are used to slow the progression of CTCL, but none that serve as curative. Recently, however, there have been a number of emerging biologic and targeted therapies that can have impressive success with treating CTCL. This article will focus on the diagnosis/treatment planning of CTCL as well as describe several widely used treatments for CTCL.
Since cancer immunotherapy is an emerging class of treatment, many people find themselves poorly informed on the subject. Despite this, immunotherapy is poised to become the most powerful and widely used form of cancer treatment in the years to come. Already, immunotherapy is recognized by healthcare professionals as the most promising new cancer treatment approach since the production of the first chemotherapies back in the 1940s. Many professionals project that as more research is conducted, more and more immunotherapy treatments will be approved to treat more and more types of cancer. This research is dependent on the use of clinical trials, meaning the only way to get more immunotherapy treatments approved is through the cooperation of cancer patients, doctors, and scientists. Here, we will explore the potential of immunotherapy as a treatment for most (if not all) cancers, as well as discuss the importance of clinical trials to patients and scientists alike.
More than 15 million American adults are affected by depression annually, with the expectation that 16-20 out of 100 people will have the disorder at least once in their lives.(1)